← All trials
NCT05419479
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2022
- Primary completion
- Jan 31, 2026
- Completion date
- Sep 30, 2028
- First posted
- Jun 15, 2022
- Last posted
- Jun 15, 2022
- Enrollment
- 46
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityOverall official - principal investigator
- Harvard UniversitySponsor investigator
- Lustgarten FoundationCollaborator
- Arcus Biosciences, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.